Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
30 analysts
Options Flow (P/C)
—
Avg Consensus PT
$71
+40.7%
Highest Price Target
$120
+136.2%
Lowest Price Target
$32
-37.0%
Short Interest
22.1%
Declining — Bullish
Insider Activity (30d)
Neutral
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | UBS | Joon Lee— | +2.4% | $52 | Initiate | Neutral |
| Aug 31, 2026 | Citizens | Silvan Turkcan— | +57.5% | $80 → $80 | Maintained | Market Outperform |